Posts by Kayla Shields
Homeopathic Certifications & Compliances
Given the importance that natural shoppers and natural product retailers place on certifications that ensure pure ingredients, ethically produced products, and protection of the environment, investing in key certifications may…
Read MoreHealth Care/OTC Legislative Issues: What’s in Store on Capitol Hill
The Federal Trade Commission recently published rules regarding consumer endorsements and testimonials which take effect in less than two months. The rules are wide ranging and cover: relationships , compensation, prohibitions, misrepresentation or far more. Violators will be fined under the new rules. The AAHP has prepared a brief overview of …
Read MoreEarly Impact of the Trump Administration
The Federal Trade Commission recently published rules regarding consumer endorsements and testimonials which take effect in less than two months. The rules are wide ranging and cover: relationships , compensation, prohibitions, misrepresentation or far more. Violators will be fined under the new rules. The AAHP has prepared a brief overview of …
Read MoreHow Government Decisions Impact the Homeopathy Industry
Homeopathy, like all sectors of the healthcare industry, is subject to oversight and influence from various parts of the U.S. government. From Congress to regulatory agencies, different entities play a…
Read MorePotential Nitrosamine Impurities in Your Products?
By Robert Sven Jechlitschka, Director of Quality and Development, Schwabe Pharma México In September 2024, the Food and Drug Administration published a final guidance document on Control of Nitrosamine Impurities…
Read MoreLowest Permissible Attenuation
By Eric L. Foxman, HPCUS Senior Scientist While many might be familiar with the nomenclature and concept of “First Safe Dilution” (FSD), the Homeopathic Pharmacopeia Convention of the United States…
Read MoreUpdate — Lawsuit Challenges FDA’s Homeopathic Regulatory Policy
By Alvin J. Lorman, AAHP Counsel The lawsuit filed last October challenging FDA’s characterization of homeopathic products as unapproved new drugs will not be decided before the second quarter of…
Read MoreAAHP 2025 Outlook
By Mark Land, M.S., RAC-US, AAHP President To support the growth of member companies’ businesses and address issues in our new environment, the AAHP Board developed the following agenda built…
Read MoreA Year of Change
By Mark Land, M.S., RAC-US, AAHP President This year 2025 is poised to be one of the most dynamic years in recent memory. Everyone is aware by now of the…
Read More